These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35165019)

  • 1. Is Serenoa repens effective for the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)? A systematic review and meta-analysis.
    Lok W; Lin T; Cao D; Wei Q
    Asian J Surg; 2022 Sep; 45(9):1746-1747. PubMed ID: 35165019
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial.
    Giammusso B; Di Mauro R; Bernardini R
    Arch Ital Urol Androl; 2017 Mar; 89(1):17-21. PubMed ID: 28403589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flower Pollen Extract in Association with Vitamins (Deprox 500®) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments.
    Macchione N; Bernardini P; Piacentini I; Mangiarotti B; Del Nero A
    Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):151-161. PubMed ID: 30488800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.
    Kaplan SA; Volpe MA; Te AE
    J Urol; 2004 Jan; 171(1):284-8. PubMed ID: 14665895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nanoparticle-coupled T2 peptide induces immune tolerance and ameliorates chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in mice model.
    Cao Y; Cheng Y; Ihsan AU; Khan FU; Xie D; Cui X; Wang W; Zhou X
    Fundam Clin Pharmacol; 2019 Jun; 33(3):267-276. PubMed ID: 30471234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
    BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
    BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pirfenidone on rat chronic prostatitis/chronic pelvic pain syndrome and its mechanisms.
    Peng X; Guo H; Chen J; Wang J; Huang J
    Prostate; 2020 Sep; 80(12):917-925. PubMed ID: 32569423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic approach to the management of the chronic prostatitis/chronic pelvic pain syndrome.
    Nickel JC; Shoskes DA
    BJU Int; 2010 Nov; 106(9):1252-63. PubMed ID: 20946349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.
    Magri V; Marras E; Restelli A; Wagenlehner FM; Perletti G
    Exp Ther Med; 2015 Mar; 9(3):658-666. PubMed ID: 25667610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management.
    Luzzi GA
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):253-6. PubMed ID: 12195565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge domain and emerging trends in chronic prostatitis/chronic pelvic pain syndrome from 1970 to 2020: a scientometric analysis based on VOSviewer and CiteSpace.
    Liu SJ; Gao QH; Deng YJ; Zen Y; Zhao M; Guo J
    Ann Palliat Med; 2022 May; 11(5):1714-1724. PubMed ID: 35144392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D; Wang P; Chen J; Wang S; Jiang H
    Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promise and the Pharmacological Mechanism of Botulinum Toxin A in Chronic Prostatitis Syndrome.
    Chen CH; Tyagi P; Chuang YC
    Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jiedu Huoxue decoction improves chronic abacterial prostatitis/chronic pelvic pain syndrome through activating Wnt/GSKβ/β-catenin signaling pathway and alleviating apoptosis.
    Yi J; Pan J; Zhang S; Mao W; Wang J; Wang W; Yan Z
    Biomed Pharmacother; 2022 May; 149():112830. PubMed ID: 35306428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials.
    Yang G; Wei Q; Li H; Yang Y; Zhang S; Dong Q
    J Androl; 2006; 27(6):847-52. PubMed ID: 16870951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of selective serotonin re-uptake inhibitors for chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis.
    Lao Y; He L; Zhang P; Dong Z
    Asian J Surg; 2022 Dec; 45(12):2810-2812. PubMed ID: 35739025
    [No Abstract]   [Full Text] [Related]  

  • 20. Interventions to chronic prostatitis/Chronic pelvic pain syndrome treatment. Where are we standing and what's next?
    Appiya Santharam M; Khan FU; Naveed M; Ali U; Ahsan MZ; Khongorzul P; Shoaib RM; Ihsan AU
    Eur J Pharmacol; 2019 Aug; 857():172429. PubMed ID: 31170381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.